Distinguishing between "good" and "bad" uses of gene therapy involves ethical

considerations and societal values. Generally, uses that alleviate suffering, treat
diseases, and improve quality of life are seen as positive, while those that
enhance superficial traits or perpetuate inequality may be viewed negatively.

Deciding which traits constitute a disability or disorder often involves a

combination of medical consensus, cultural norms, and societal values. It's a
complex process that may vary across different communities and time periods.

The high costs of gene therapy could indeed limit access to those who can afford
it, raising concerns about equity and fairness in healthcare. Efforts are needed to
ensure access for all, regardless of financial means.

The widespread use of gene therapy could potentially lead to societal shifts in
attitudes towards diversity and differences. It's important to promote acceptance
and inclusivity while embracing the diversity of human traits and experiences.

The question of whether people should be allowed to use gene therapy to

enhance basic human traits like height, intelligence, or athletic ability is deeply
ethical and requires careful
consideration of potential consequences. It raises concerns about equity,
fairness, and the potential for unintended societal consequences. Ethical
guidelines and regulations are necessary to navigate these complex issues
responsibly.